Pharmacokinetic and Pharmacodynamic Properties of Single- and Multiple-Dose of Dapagliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese SubjectsYang Li, David W. Boulton, Haiyan Li et al.|Clinical Therapeutics|2013Cited by 43
Reduction effect of oral pravastatin on the acute phase response to intravenous zoledronic acid: protocol for a real-world prospective, placebo-controlled trialQi Liu, Chunli Song, Guohong Du et al.|BMJ Open|2022Cited by 6